Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
345 studies found for:    Mesothelioma
Show Display Options
Rank Status Study
1 Completed Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
2 Active, not recruiting Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma
Condition: Mesothelioma
Intervention: Behavioral: Questionnaires & online virtual support group
3 Completed Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
Condition: Peritoneal Mesothelioma
Intervention: Genetic: comparative genomic analysis
4 Completed Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)
Condition: Malignant Pleural Mesotheliomas
Intervention: Other: marker CD74 and vascular endothelial growth factor VEGF
5 Active, not recruiting Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: HSV1716 Intra-pleural delivery
6 Recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention:
7 Completed
Has Results
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: everolimus
8 Completed Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: pemetrexed;   Drug: cisplatin
9 Unknown  Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients
Condition: Mesothelioma
Intervention: Biological: MesoCancerVac
10 Unknown  An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Milataxel
11 Recruiting Trial of Adcetris in CD30+ Malignant Mesothelioma
Conditions: Lung Diseases Due to External Agents;   Mesothelioma
Intervention: Drug: Brentuximab Vedotin
12 Completed Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Imatinib Mesylate;   Drug: Pemetrexed;   Drug: Dexamethasone
13 Completed Tomotherapy Treatment for Mesothelioma
Condition: Mesothelioma
Intervention: Procedure: Tomotherapy
14 Completed Serum Biomarkers in Diagnosis of Mesothelioma
Condition: Mesothelioma
Intervention: Biological: Mesothelin, hyaluronan, osteopontin, syndecan-1
15 Completed Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Erlotinib;   Drug: Bevacizumab
16 Unknown 
Has Results
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Oxaliplatin/Gemcitabine
17 Terminated Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: defactinib (VS-6063);   Drug: Placebo
18 Unknown  Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
Conditions: Mesothelioma;   Lung Cancer
Intervention:
19 Recruiting Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma;   Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Methotrexate;   Drug: Gemcitabine;   Other: Lung Cancer Symptom Scale for Mesothelioma Questionnaire
20 Completed An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention: Drug: ZD1839

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.